companydata.dkARXX Therapeutics ApS
CVR: 40868151
ARXX Therapeutics ApS is experiencing a decline in revenue and profitability, with 2024 revenue at 2,608,206 DKK, down from 2,790,576 DKK in 2023, and profit decreasing to 116,729 DKK from 269,759 DKK. Despite this downturn, the company's equity has improved to 982,209 DKK, indicating a stronger financial foundation compared to previous years. The revenue trend shows volatility, peaking at 5,789,922 DKK in 2022 before a significant drop, raising concerns about sustainability and market position within the pharmaceutical manufacturing industry. Overall, while equity growth is a positive sign, the declining revenue and profit margins suggest challenges ahead.
AI-generated summary
Overview
- Company type
- APS
- Anpartsselskab
- Founded
- 1.10.2019
Details
- Capital
- 100.000 kr.
Purpose
Selskabets formål er at udvikle, markedsføre og sælge lægemidler samt al virksomhed, som efter direktionens skøn er beslægtet hermed
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 2.6 mio. | 117 t. | 1.4 mio. | 982 t. | - | |
History
Ownership
Management
Directors
Founders
Production units (1)
Similar companies
Companies in the same industry and area